Orinda, CA, United States of America

Byeong S Chang


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Byeong S Chang in M-CSF Purification**

Introduction

Byeong S Chang is an accomplished inventor based in Orinda, California. He has made significant strides in the field of biotechnology, particularly in the optimization of protein production processes. With a focus on the purification of biologically produced proteins, his innovations have the potential to enhance the efficacy and production of therapeutic agents.

Latest Patents

Chang holds a patent for a method titled "Process for purifying bacterially produced M-CSF." This process involves several critical steps: fermentation of bacteria containing the M-CSF DNA, harvesting of fractions with the M-CSF protein, primary recovery, solubilization, and denaturation of refractile bodies. Following these steps, Chang's method includes M-CSF refolding, purification through column chromatography, and final formulation of the correctly refolded M-CSF. This innovative approach boasts advantages over previous methods, particularly in terms of yield and purity.

Career Highlights

Byeong S Chang is associated with Chiron Therapeutics, a leading organization in the biopharmaceutical industry. His work focuses on the refinement and enhancement of processes that contribute to the development of therapeutic proteins, fostering advancements in medical treatments.

Collaborations

Throughout his career, Chang has collaborated with notable colleagues, including Glenn J Dorin and David R Gray. These collaborations have enabled him to leverage a collective expertise that enhances the development of biotechnological innovations within his field.

Conclusion

Byeong S Chang's contributions to the domain of protein purification represent a significant leap forward in biotechnological processes. His patented methods hold the promise of improving the yield and purity of therapeutic agents, thereby potentially influencing the effectiveness of treatments in the medical landscape. With a strong foundation in research and collaboration, Chang continues to be a vital figure in the advancement of biopharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…